Drug Profile
Anti-CD22 monoclonal antibody-saporin-6 complex
Latest Information Update: 26 Aug 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action CD22 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-Hodgkin's lymphoma
Most Recent Events
- 03 Sep 1998 Profile reviewed
- 26 Sep 1995 Investigation in Non-Hodgkin's lymphoma in United Kingdom (Infusion)